Werner Cautreels
CIK 1237419 · Chief Executive Officer · last filed 2026-07-15
Werner Cautreels is a Chief Executive Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for TRAW, was dated Jul 15, 2026. Across all open-market trades the lifetime net is +$186.2K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $37.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SELB price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BRYN MAWR, PA 19010
Holdings By Company
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-15 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2026-03-10 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-12-16 | TRAW | Grant (A) | +4,874 | $0 | EDGAR |
| 2025-10-15 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-06-23 | TRAW | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | TRAW | Exer (M) | +96,348 | $963 | EDGAR |
| 2025-01-27 | TRAW | Buy (P) | — | $0 | EDGAR |
| 2024-04-03 | TRAW | Grant (A) | +200,000 | $0 | EDGAR |
| 2017-11-14 | Cartesian Therapeutics, Inc. (SELB) Delisted | Buy (P) | +20,000 | $186.2K | EDGAR |
| 2017-07-11 | Cartesian Therapeutics, Inc. (SELB) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.